Safe Orthopaedics Appoints Chief Financial Officer

Safe Orthopaedics SA has appointed a new chief financial officer (CFO).

Thierry Lambert’s main task will be to handle the company’s finances and administrative affairs, working closely with executive management. Safe Orthopaedics executives believe the firm will benefit from Lambert’s international vision and experience of overseeing the company’s finances as it expands into international markets.

Lambert, 37, has 15 years of experience working in financial positions at various companies. In 2009, he joined the Naturex group as corporate finance manager and worked his way up to Group CFO. Previously, Lambert held various positions at CIT and PricewaterhouseCoopers in the United Kingdom, where he worked on mergers and acquisitions and leveraged finance. He is a qualified United Kingdom-chartered accountant and also holds an MBA from INSEAD, a graduate business school with campuses in Europe, Asia, and the Middle East.

In 2014, Lambert was ranked by DAF Magazine as one of the 50 most influential CFOs in France.

“We are delighted to welcome Thierry Lambert to our team”, said Yves Vignancour, CEO of Safe Orthopaedics.“His international experience and strong financial expertise gained at an international group will be crucial assets for us as we look to step up our international expansion in Europe, the United States and around the world.”

Founded in 2010, Safe Orthopaedics develops and markets sterile implants and associated single-use surgical instruments. Protected by 17 patent families, the company’s CE-marked and U.S. Food and Drug Administration-approved SteriSpine kits are sold in 12 countries. The company is based in Eragny‑sur‑Oise, France, and has 33 employees and a U.S. subsidiary.